Methods and compositions for inducing apoptosis in cancer cells
US7229617B2 · kind B2 · utility
18Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 2003 |
| Grant date | Jun 12, 2007 |
| Priority date | — |
| Expiry date | Dec 30, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-DR4 or Anti-DR5 antibody agonists, combined with apoptosis-inducing agents, synergistically induce apoptosis in cancer cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.